Gregory Burshtein

Insider Reports History

Location
Jerusalem, Israel
Signature
/s/ Dana Yaacov-Garbeli, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gregory Burshtein:

Company Role Class Num Shares Value Price $ Report Date Ownership
Entera Bio Ltd. Chief of R&D Ordinary Shares, par value NIS 0.0000769 per share 101,442 $208,970 $2.06 16 Jul 2025 Direct
Entera Bio Ltd. Chief of R&D Stock Option (right to buy) 200,000 16 Jul 2025 Direct

Insider Reports Filed by Gregory Burshtein

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ENTX Entera Bio Ltd. 16 Jul 2025 2 $0 4 Chief of R&D 18 Jul 2025, 16:35
ENTX Entera Bio Ltd. 28 May 2024 0 $0 3 Chief of R&D 07 Jun 2024, 16:05